Lebrikizumab Improved Skin Signs, Quality of Life, and Showed High Levels of Patient Satisfaction in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis and Skin of Color. (2025). SKIN The Journal of Cutaneous Medicine, 9(2), s549. https://doi.org/10.25251/skin.10.supp.549